MannKind is trading 5.17% down now at $3.94 as broader markets remain under pressure.
- The S&P 500 is down 0.49%, the NASDAQ Composite is down 0.62%, and the Dow Jones is down 0.81%.
- Oil prices exceed $100 per barrel amid escalating U.S.-Iran tensions.
- MannKind announced a Rose Pharma licensing collaboration for an inhaled GLP-1 program on September 9, 2026; available coverage does not explicitly connect it to the decline.